Lecanemab

1 Drug classified under this active ingredient

Monoclonal Antibody. Lecanemab 100 mg/ml.
Vial. Conc. for sol. for inf.1 X 2/5 ml
10 mg/kg to be diluted then admin. as an IV infus. over approx. one hour, once every two weeks
Tmt. of Alzheimer’s dis.To be initiated in pts. with mild cognitive impairment or mild dementia stage of dis., the population in which tmt. was initiated in clinical trials:
C/I:Hypersens. Reactions have included angioedema and anaphylaxis.